Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Capital Expenditures (2023 - 2025)

Ardent Health (ARDT) has 3 years of Capital Expenditures data on record, last reported at $114.6 million in Q3 2025.

  • For Q3 2025, Capital Expenditures rose 13.16% year-over-year to $114.6 million; the TTM value through Sep 2025 reached $209.2 million, down 9.23%, while the annual FY2024 figure was $187.5 million, 36.46% up from the prior year.
  • Capital Expenditures reached $114.6 million in Q3 2025 per ARDT's latest filing, up from -$9.6 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $124.2 million in Q4 2023 and bottomed at -$9.6 million in Q2 2025.
  • Average Capital Expenditures over 3 years is $49.3 million, with a median of $22.9 million recorded in 2025.
  • Peak YoY movement for Capital Expenditures: soared 2324.14% in 2024, then crashed 357.99% in 2025.
  • A 3-year view of Capital Expenditures shows it stood at $124.2 million in 2023, then plummeted by 34.57% to $81.3 million in 2024, then soared by 41.05% to $114.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $114.6 million in Q3 2025, -$9.6 million in Q2 2025, and $22.9 million in Q1 2025.